selected publications
-
Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review.
Pharmacogenomics and personalized medicine.
2023
Review
GET IT
Times cited: 13 -
Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis.
Blood advances.
2022
Review
GET IT
Times cited: 2 -
Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma.
2022
GET IT
Times cited: 3 -
Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review.
Survey of ophthalmology.
2021
Review
GET IT
Times cited: 10 - Neurolymphomatosis of the median nerve, optic nerve, L4 spinal nerve root and cauda equina in patients with B-cell malignancies: a case series. Journal of medical case reports. 2021 Academic Article GET IT
-
The Role of Integrated Positron Emission Tomography/Computed Tomography (PET/CT) and Bone Marrow Examination in Staging Large B-Cell Lymphoma.
Clinical Medicine Insights. Oncology.
2020
Academic Article
GET IT
Times cited: 1 -
The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic.
Journal of thrombosis and thrombolysis.
2020
Academic Article
GET IT
Times cited: 4 -
A persistent cough as atypical clinical presentation of intrathoracic extramedullary hematopoiesis (EMH) in a female with thalassemia intermedia.
2018
GET IT
Times cited: 3 -
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
British journal of haematology.
2017
Academic Article
GET IT
Times cited: 18 -
Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC.
Leukemia research.
2014
Academic Article
GET IT
Times cited: 3 -
Survival of myeloma patients following the introduction of thalidomide as a second-line therapy: a retrospective study at a single New Zealand centre.
Internal medicine journal.
2013
Academic Article
GET IT
Times cited: 2 -
Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
Analytical and bioanalytical chemistry.
2012
Academic Article
GET IT
Times cited: 10 -
Relative recovery of haematopoietic stem cell products after cryogenic storage of up to 19 years.
Bone marrow transplantation.
2012
Academic Article
GET IT
Times cited: 26 -
CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.
Internal medicine journal.
2010
Academic Article
GET IT
Times cited: 9 -
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia.
Leukemia research.
2009
Academic Article
GET IT
Times cited: 25 -
The cardiovascular risk factor, soluble CD40 ligand (CD154), but not soluble CD40 is lowered by ultra-endurance exercise in athletes.
British journal of sports medicine.
2008
Academic Article
GET IT
Times cited: 5 - Marrow fibrosis and pure red cell aplasia complicating early stage chronic lymphocytic leukaemia. Pathology. 2005 Letter GET IT
-
Comparison of in vivo and in vitro rat hepatic toxicity of coumarin and methyl analogues, and application of quantitative morphometry to toxicity in vivo.
Toxicology.
1994
Academic Article
GET IT
Times cited: 16